Global Stories
Voices from Gaza: Rationing Expired Insulin and No Test Strips
16 Feb 2026, 3:18 p.m. in Global Stories, Interviews by Ali Hisham and Mohammed Seyam
People living with diabetes in Gaza have suffered for years under constrained health services due to Israeli blockades. In recent years, this suffering has escalated to unimaginable levels. Insulin, diabetes supplies, and even food became almost entirely unavailable as violence intensified and entire neighbourhoods turned into battlefields.
In the last few weeks, I interviewed three people from Gaza to share their testimonies of living with type 1 diabetes there.
Read more
T1International Year in Review: 2025
18 Dec 2025, 8:23 p.m. in #insulin4all USA, Global Stories, News & Statements by T1International
Throughout 2025, T1International’s global network advanced critical work to improve access to insulin and diabetes supplies. Across regions, our community organized events, met with legislators, shared their experiences, and pushed for structural change.
Read more
World Diabetes Day 2025: Advocates stand together for Access, Affordability, and Action
16 Nov 2025, 7:39 p.m. in #insulin4all USA, Global Stories by T1International
On November 14th, 2025, World Diabetes Day, #insulin4all advocates across the globe came together to make a demand: that they be able to access and afford their life-sustaining medications. Recent data showed that 1 in 3 people around the world rationed their insulin due to cost in 2024. At T1International, we know that #insulin4all is a reasonable and dignified demand– and yet, we are still too far from achieving a reality where everyone, no matter where they live, has access to the medicine and supplies they need to survive and flourish. Read more
Fighting for Survival: The Insulin Crisis in the Democratic Republic of Congo
23 Sep 2025, 8:02 p.m. in Global Stories by T1International
In the Democratic Republic of Congo (DRC), living with type 1 diabetes is not only a daily challenge–it’s a fight for survival. Access to insulin is deeply unequal and increasingly precarious due to conflict, economic instability, and fragile health systems. Two members of the T1International network, Dr. Kalehezo Murhabazi Albert and Professor Justin Cikomola Cirhuza, share a glimpse into what this crisis looks like on the ground. Read more
World Health Organization Approves Rapid-Acting Insulin Analogues to the 24th EML
5 Sep 2025, 2:56 p.m. in Global Stories, News & Statements by T1International
Global Diabetes Advocates Urge Novo Nordisk’s New CEO to Prioritize People Over Profits
7 Aug 2025, 8:27 p.m. in #insulin4all USA, Global Stories, News & Statements by T1International
Findings from T1International's 2024 Out-of-Pocket Expenses and Rationing Survey
28 May 2025, 4:15 p.m. in #insulin4all USA, Global Stories by T1International
Progress on Insulin Access: Adding Rapid-Acting Insulin Analogues to the Essential Medicines List
9 Apr 2025, 10:04 p.m. in Global Stories, News & Statements by T1International
T1International Year in Review: 2024
15 Dec 2024, 11:41 a.m. in #insulin4all USA, Global Stories, News & Statements by T1International
As 2024 comes to an end, we’re taking a moment to reflect on the collective power of the T1International community. This year has been filled with challenges and victories as we’ve worked together to fight for affordable and accessible insulin. Here’s a month-by-month look at what we’ve accomplished, thanks to your support and the dedication of advocates across the globe. Read more
Make it Right: The Fight for Insulin Access on World Diabetes Day
20 Nov 2024, 6:19 p.m. in #insulin4all USA, Global Stories by Shaina Kasper
On World Diabetes Day, we shine a spotlight on a glaring injustice: millions of people with diabetes in low- and middle-income countries are denied access to affordable insulin pens—a delivery method that could save and transform lives. Pharmaceutical giants Eli Lilly, Novo Nordisk, and Sanofi have monopolized the diabetes market, prioritizing profit over people. It’s time to demand change. It’s time to make it right. Read more